Search

Author/Creator Sam, Johannes

1. Anti-tumoral, anti-angiogenic and anti-metastatic efficacy of a tetravalent bispecific antibody (TAvi6) targeting VEGF-A and angiopoietin-2. Issue 3 (2nd April 2016)

Authors:
Scheuer, Werner; Thomas, Markus; Hanke, Petra; Sam, Johannes; Osl, Franz; Weininger, Diana; Baehner, Monika; Seeber, Stefan; Kettenberger, Hubert; Schanzer, Jürgen; Brinkmann, Ulrich; Weidner, K. Michael; Regula, Jörg; Klein, Christian
Journal:
MAbs
Issue:
Volume 8:Issue 3(2016)
Page Start:
562
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Innovations, challenges, and minimal information for standardization of humanized mice. Issue 7 (24th June 2020)

Authors:
Stripecke, Renata; Münz, Christian; Schuringa, Jan Jacob; Bissig, Karl‐Dimiter; Soper, Brian; Meeham, Terrence; Yao, Li‐Chin; Di Santo, James P; Brehm, Michael; Rodriguez, Estefania; Wege, Anja Kathrin; Bonnet, Dominique; Guionaud, Silvia; Howard, Kristina E; Kitchen, Scott; Klein, Florian; Saeb‐...
Journal:
EMBO molecular medicine
Issue:
Volume 12:Issue 7(2020)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. ITOC2 – 037. CEA TCB, A novel T-cell bispecific antibody with potent in vitro and in vivo antitumour activity against solid tumours. (March 2015)

Authors:
Bacac, Marina; Fauti, Tanja; Colombetti, Sara; Sam, Johannes; Nicolini, Valeria; Steinhoff, Nathalie; Ast, Oliver; Bruenker, Peter; Hosse, Ralf; Hofer, Thomas; Moessner, Ekkehard; Jaeger, Christiane; Saro, Jose; Karanikas, Vaios; Klein, Christian; Umaña, Pablo
Journal:
European journal of cancer
Issue:
Volume 51(2015)Supplement 1
Page Start:
S13
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. JAK and mTOR inhibitors prevent cytokine release while retaining T cell bispecific antibody in vivo efficacy. Issue 1 (21st January 2022)

Authors:
Leclercq, Gabrielle; Haegel, Hélène; Toso, Alberto; Zimmermann, Tina; Green, Luke; Steinhoff, Nathalie; Sam, Johannes; Pulko, Vesna; Schneider, Anneliese; Giusti, Anna Maria; Challier, John; Freimoser-Grundschober, Anne; Larivière, Laurent; Odermatt, Alex; Stern, Martin; Umana, Pablo; Bacac, Mari...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 10:Issue 1(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Simlukafusp alfa (FAP-IL2v) immunocytokine is a versatile combination partner for cancer immunotherapy. Issue 1 (1st January 2021)

Authors:
Waldhauer, Inja; Gonzalez-Nicolini, Valeria; Freimoser-Grundschober, Anne; Nayak, Tapan K; Fahrni, Linda; Hosse, Ralf J.; Gerrits, Danny; Geven, Edwin J. W.; Sam, Johannes; Lang, Sabine; Bommer, Esther; Steinhart, Virginie; Husar, Elisabeth; Colombetti, Sara; Van Puijenbroek, Erwin; Neubauer, Mar...
Journal:
MAbs
Issue:
Volume 13:Issue 1(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Src/lck inhibitor dasatinib reversibly switches off cytokine release and T cell cytotoxicity following stimulation with T cell bispecific antibodies. Issue 7 (29th July 2021)

Authors:
Leclercq, Gabrielle; Haegel, Hélène; Schneider, Anneliese; Giusti, Anna Maria; Marrer-Berger, Estelle; Boetsch, Christophe; Walz, Antje-Christine; Pulko, Vesna; Sam, Johannes; Challier, John; Ferlini, Cristiano; Odermatt, Alex; Umaña, Pablo; Bacac, Marina; Klein, Christian
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 9:Issue 7(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗